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doi:10.1016/j.ejvs.2011.06.021Abstract Objectives: To compare percutaneous transluminal angioplsty (PTA) against exer-
cise training in the treatment of stable claudication.
Design: Prospective, randomised trial.
Materials: Fifty-six patients with unilateral, stable, lower limb claudication assessed prior to
randomisation, at 3 monthly intervals for 15 months, and at approximately 6 years follow-
up. Thirty-seven patients were available for long term review.
Outcome measures: Ankle/brachial pressure index (ABPI), treadmill claudication and
maximum walking distances, percentage fall in ankle systolic pressure after exercise.
Results: Significant increases were seen in ABPI in the patients treated with PTA at all assess-
ment to 15 months. However in terms of improved walking performance, the most significant
changes in claudication and maximum walking distance were seen in the exercise training
group. At long term follow-up, there was no significant difference between the groups.
Subgroup analysis by angiographic site of disease showed greater functional improvement in
those patients with disease confined to the superficial femoral artery treated by exercise
training. The overall prognosis for the whole group of patients was benign, with only two
(4%) undergoing amputation.
Conclusions: Exercise training confers a greater improvement in claudication and maximumwalking
distance than PTA, especially in patients with disease confined to the superficial femoral artery.
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Percutaneous transluminal angioplasty (PTA) is an estab-
lished treatment option for patients with lower limb
intermittent claudication. It has low complication rates1
and 5 year patency rates of 80% for aortoiliac and 60% for
femoropopliteal disease.1 Exercise therapy is an alterna-
tive, non-invasive treatment for claudication that has been
shown to improve patients’ walking performance,2e4 but its
effectiveness compared to PTA has not been fully estab-
lished. A randomised, prospective trial was established to
compare these two treatment options, and preliminary
results showed a greater improvement in the medium term
following exercise therapy than after PTA.5 This paper
reports the final results of the study, including the long-
term follow-up of patients 5 years after randomisation.
Patients and Methods
Between July 1987 and September 1990, 56 patients with
stable unilateral claudication were randomised to receive
either PTA (30 patients) or to enter a supervised exercise
programme (26 patients). The entry criteria for the trial
were as follows: (1) stable unilateral claudication with
a failure of conservative management for 3 months prior to
randomisation; (2) a lesion(s) on angiography suitable for
angioplasty, as agreed by surgeons and radiologists; (3)
a maximum walking distance of less than 375 m, to allow
patients to double their treadmill maximum walking
distance within the study protocol. Patients were assessed
prior to randomisation, at 3 monthly intervals for 15
months, and finally at almost 6 years after treatment. At
each assessment, resting ankle/brachial pressure indices
(ABPI) were measured and the patients exercised on
a treadmill at 3 km/h up a 10 degree incline. Claudication
and maximum walking distances were recorded up to
a maximum of 750 m (equivalent to 15 min walking). Within
45 s of stopping exercise, the ankle systolic pressure was re
measured and expressed as a percentage of the resting
ankle systolic pressure (% fall in ankle pressure).
In May and June 1994 those patients who were still
available for review were re-evaluated to assess their long-
term progress. Thirty-seven patients (22 PTA; 15 Exercise)
were re-tested, 10 patients had died (4 PTA; 6 Exercise) and
the remaining patients were either uncontactable, too ill
for review or had undergone amputation. Excluding
patients who had died, 80% of patients who were available
were re-evaluated.
Subgroupsofpatientsdividedaccording to theangiographic
site of disease are shown in Table 1. Half of the patients in
each treatment group had disease confined to the superficial
femoral artery, and in other half a proximal iliac artery lesion
was present. The number of patent run-off vessels below
the knee did not differ significantly between groups.Table 1 Angiographic site of lesion(s) in each group.
Site of Lesion
Superficial Femoral Artery (SFA)
Iliac Artery/Iliac and Superficial Femoral Artery (IA)PTA was performed using a conventional guide-wire and
balloon catheter technique. The lumen was overdilated by
10% above normal, and the balloon inflated for two periods
of 45 s using the manufacturer’s recommended inflation
pressures. Heparin cover of 3000-5000 units was given
intra-arterially during the procedure. Post-procedure
angiograms were taken to confirm the success of the
angioplasty.
Patients randomised to the exercise training group were
invited to attend supervisedexercise classes twice aweek for
the first 6 months. After this, attendance was required on
a regular basis according to the patient’s progress. Each class
lasted 30 min. Dynamic leg exercises were performed, with
the intensity of exercise increasing as the patient’s exercise
tolerance improved. Patients were also encouraged to
perform the same exercises at home on a regular basis.
Statistical analysis
Comparison of proportions between groups was made using
either the Chi-square test with Yates correction or Fisher’s
exact probability test as appropriate. The non-parametric
data of claudication distance, maximum walking distance
and % fall in ankle pressure were analysed as paired data
sets with the pre-treatment values using the Wilcoxon
matched pairs signed rank sum test (Wilcoxon paired test).
Results
Mean age and proportions of male to female were not
significantly different between groups for the patients
reviewed. The follow-up time for the PTA group was median
74 months (range 48e83) and for the exercise group was
median 70 months (range 45e83). Pre-treatment values for
ABPI, claudication distance, maximum walking distance and
% fall in ankle pressure were similar for both groups.
In the intervening time since randomisation four
patients in the PTA group and 4 patients in the exercise
group had undergone angioplasty of the ipsilateral leg. Of
the PTA patients undergoing repeat ipsilateral angioplasty,
three had the original disease site re-angioplastied, and
one patient had a further angioplasty in a different arterial
segment. In the contralateral leg, three PTA patients and
three exercise patients had received further angioplasty.
Two patients had undergone reconstructive surgery; one in
the PTA group had an aortobifemoral graft, and one in the
exercise group had a femoro-femoral cross-over graft
donating to the ipsilateral leg. Overall in the entire rand-
omised group of 56 patients, only two (4%) had undergone
amputation.
The profile of the changes of ABPI, maximum walking
distance and % fall in ankle pressure with time are shown in
Figs. 1e3. In the interests of clarity, the data at long term
follow-up have been presented at the median follow-upPTA (n Z 30) Exercise (n Z 26)
15 13
15 13
Figure 1 Median ABPI vs. time (standard error bars).
*p Z 0.0001, yp Z 0.001, zp Z 0.005, xp Z 0.02 (Wilcoxon
paired test). (C) PTA; (B) exercise.
Figure 3 Median maximum walking distance vs. time (stan-
dard error bars). *p < 0.005, yp < 0.001, zpZ 0.0001 (Wilcoxon
paired test). (C) PTA; (B) exercise.
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range of long term follow-up lies between 45 and 83
months. Claudication distance was significantly greater
than pre-treatment values in the exercise group at 6
months (p Z 0.005), 9 months (p Z 0.001), 12 months
(p Z 0.001) and 15 months (p Z 0.0001) in contrast to the
PTA group which showed no significant improvement at any
of these time intervals.
Patients’ performance was analysed further by
subgroups according to the different patterns of disease, as
shown in Table 1. The improvement in walking ability in
patients with a proximal iliac artery lesion (IA) was
compared with that of patients who had disease confined to
the superficial femoral artery only (SFA). The changes inFigure 2 Median % fall in ankle pressure vs. time (standard
error bars). *pZ 0.01, ypZ 0.005, zpZ 0.02 (Wilcoxon paired
test). (C) PTA; (B) exercise.claudication distance and maximum walking distance for
patients with IA or SFA disease are shown in Figs. 4 and 5.
Significant increases in ABPI were seen only in the group
receiving PTA, regardless of the site of disease. The ABPI
showed an increase at 3 (p Z 0.002), 6 (p Z 0.01), 9
(p Z 0.01), and 15 (p Z 0.04) months for the SFA group
treated with angioplasty, and at 3 (pZ 0.03), 6 (pZ 0.003)
and 9 (pZ 0.02) months for the IA group. In contrast, none
of the exercise training patients (both IA and SFA) had any
significant increase in ABPI during this same time.
At long term follow-up, only two patients admitted to
continuing to perform the exercises every day, andFigure 4 Median claudication distance vs. time (standard
error bars). Subgroup analysis according to site of disease (IA or
SFA). *p Z 0.01, yp Z 0.009, zp Z 0-008 (Wilcoxon paired
test). (C) SFA PTA; (B) SFA exercise; (-) IA PTA; (,) IA
exercise.
Figure 5 Median maximum walking distance vs. time (stan-
dard error bars). Subgroup analysis according to site of disease
(IA or SFA). *pZ 0.02, ypZ 0.004, zpZ 0.003, xpZ 0.005, j j;
p Z 0.001 (Wilcoxon paired test). (C) SFA PTA; (B) SFA
exercise; (-) IA PTA; (,) IA exercise.
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week. The remainder exercised only sporadically. Nine of
the 22 patients (41%) reviewed in the PTA group and 8 out of
15 (53%) in the exercise group continued to smoke.Discussion
Over the past decade percutaneous transluminal angio-
plasty (PTA) has been increasingly used as the first-line
treatment for lower limb ischaemia, either alone or in
conjunction with reconstructive surgery.6 This preference
for the use of PTA over the more conservative management
of exercise training appears to have arisen from an
unproven perception that PTA produced a better outcome
for patients. This prospective, randomised study clearly
shows that the increases in claudication distance and
maximum walking distance experienced by patients
enrolled into an exercise programme were significantly
greater than those in patients undergoing PTA. These
increases in both claudication distance and maximum
walking distance in those randomised to the exercise pro-
gramme are in line with those in non-randomised observa-
tional studies on exercise training.2,3
The beneficial effects of exercise training are not simply
produced by an increase in collateral blood flow. The studies
of Larsen and Lassen2 and Ekroth et al3 showed no increase in
limbbloodflowasmeasured byXenon-133 clearance studies2
or strain gauge plethysmography,3 observations that are
supported by the lack of increase in ABPI seen in the exercise
group in our study. At a cellular level, exercise promotes
changes in the enzymatic activity,7,8 and the size and
numbers of mitochondria within the muscle,9 this allowing
more efficient utilisation of oxygen. Substrate extraction
fromblood is enhanced.10Withinmuscle, there is a change of
fibre type, with an increase in Type 1 fibres,11 which are
characterised by a more dense capillary network, thusallowing more efficient delivery of substrate to the muscle.
Blood fluidity, characterised by an increase in red cell
deformity anda reduction in blood viscosity,12 is increasedby
exercise training.
Previous studies have suggested that thebeneficial effects
of exercise training are seen regardless of the site of disease.3
The subgroup analysis of the patients in this study according
to the site of the lesion, does not support this view, although
the numbers in each group are small. The most significant
improvement was seen in patients with disease confined to
the superficial femoral artery.Disease in this arterial segment
is often multifocal, and the results of angioplasty within the
femoropopliteal segment are less convincing. The relatively
small number of patients in each subgroup prevent absolutely
definitive conclusions from being reached, but would support
recommending exercise training as the initialmanagement of
choice in stable claudicantswith lesions in theSFAonly. This is
an area for further investigation.
In the long-term the functional outcome between the two
groups was identical. The results show a small, but non-
significant increase in all parameters in both groups
compared to pre-treatment values, with an encouragingly
benign long-termprogress regardless of treatment option. The
amputation rate for the entire randomised group of patients
and the rate of surgical intervention are similar to those
reported in studies of the natural history of intermittent
claudication.13e15 The benign natural history of intermittent
claudication is confirmed by our study irrespective of whether
the treatment given initially was PTA or exercise therapy.
In conclusion, we suggest that many patients currently
treated with PTA would be suitable for, and benefit from
exercise training. Although the complication rate of PTA is
low, nonetheless a small percentage (2%) of patients will
require surgery to correct complications.16 There are no
complications of exercise training, nor does it compromise
subsequent PTA or surgery should they be necessary.
Exercise training has the additional merit of promoting
a generalised feeling of well-being.2 Some patients with
coexisting cardiac or arthritic conditions may be prevented
from exercising, and some younger patients who are still in
full employment may find the exercise programme exces-
sively time-consuming, but these are small subgroups and
the majority of patients with stable intermittent claudica-
tion would gain a significant improvement in walking
performance from enrolment into an exercise programme.
The use of exercise training as an adjunctive treatment
following reconstructive surgery has been shown to improve
the benefit conferred by such surgery17 and it is possible
that the combination of PTA and exercise training may
confer the maximal advantage to the patient. This requires
further investigation. Long-term fears for the viability of
limbs in patients treated with exercise training are not
justified. Although the benefits of exercise therapy are not
sustained in the long term, because patients tend to stop
exercising as time goes by, the long term outcome is
identical to patients who receive treatment with PTA.
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